首页 | 本学科首页   官方微博 | 高级检索  
     

高血压3种治疗药物的成本-效果分析
引用本文:陈元成. 高血压3种治疗药物的成本-效果分析[J]. 职业与健康, 2012, 28(5): 618-619
作者姓名:陈元成
作者单位:天津市职业病防治院(工人医院),300011
摘    要:
目的对抗高血压联合用药进行成本-效果分析。方法以3组高血压联合药物方案:A组(氨氯地平5 mg,早晨服),B组(福辛普利10 mg,早晨服),C组(非洛地平5 mg,早晨服),采用药物学手段进行分析评价。结果 3组药物治疗高血压的总有效率分别为96.0%、84.0%、88.0%,经比较,差异无统计学意义(P0.05);C组成本最低,有较好的成本-效果比。结论非洛地平为临床较合理的抗高血压药物。

关 键 词:成本效果分析  原发性高血压  氨氯地平  福辛普利  非洛地平缓释片

Cost-effectiveness analysis of three drugs for hypertension
CHEN Yuan-cheng. Cost-effectiveness analysis of three drugs for hypertension[J]. Occupation and Health, 2012, 28(5): 618-619
Authors:CHEN Yuan-cheng
Affiliation:CHEN Yuan-cheng Tianjin Institute for Occupational Disease Prevention and Control(Workers’ Hospital),Tianjin,530021,China
Abstract:
[Objective]To carry out a cost-effectiveness analysis of drug combination for hypertension. [Methods]There were three schemes of drug combination for hypertension: group A(amlodipine 5 mg,administration in the morning),group B(fosinopril 10 mg,administration in the morning),and group C(felodipine 5 mg,administration in the morning).The analysis and evaluation was conducted by medicinal methods. [Results]The total effective rate of three groups was 96.0% and 84.0% respectively,and the difference was not significant(P>0.05).The cost of group C was the lowest,and it had better cost-effectiveness ratio. [Conclusion]Felodipine is a reasonable drug for hypertension in clinic.
Keywords:Cost-effectiveness analysis  Primary hypertension  Amlodipine  Fosinopril  Felodipine
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号